Voya Investment Management LLC Solid Biosciences Inc. Transaction History

Voya Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $10,047 - $28,975	-23,367 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.46 $1,159 - $1,687	-686 Reduced 2.85%	23,367 $41,000
Q2 2021 Aug 16, 2021	BUY	$3.49 - $5.51 $38,047 - $60,070	10,902 Added 82.9%	24,053 $88,000
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $7,867 - $15,704	1,465 Added 12.54%	13,151 $73,000
Q4 2020 Feb 16, 2021	BUY	$3.08 - $7.79 $35,992 - $91,033	11,686 New	11,686 $89,000
Q2 2020 Aug 14, 2020	SELL	$2.1 - $3.42 $23,774 - $38,717	-11,321 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $31,925 - $146,040	11,321 New	11,321 $50,000
Q4 2018 Feb 14, 2019	SELL	$21.32 - $46.34 $101,568 - $220,763	-4,764 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$36.35 - $51.7 $173,171 - $246,298	4,764 New	4,764 $225,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.